{"rows":[{"id":5676,"title":"Psilocybin therapy for adult females with anorexia nervosa: pilot study","authors":"Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.","journal":"The British Journal of Psychiatry","publication_date":"2026-07-08","publication_year":2026,"doi":"10.1192/bjp.2026.10687","pubmed_id":"42414058","openalex_id":"https://openalex.org/W7167587921","source_url":"https://doi.org/10.1192/bjp.2026.10687","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-08 01:20:22","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42414058","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1192/bjp.2026.10687","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42414058","source_url":"https://doi.org/10.1192/bjp.2026.10687","doi":"10.1192/bjp.2026.10687","pmid":"42414058","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}},{"id":119,"title":"Human brain changes after first psilocybin use","authors":"Lyons T., Spriggs M., Kerkelä L., Rosas F. E., Roseman L., Mediano P. A. M., Timmermann C., Oestreich L., Pagni B. A., Zeifman R. J., Hampshire A., Trender W., Douglass H. M., Girn M., Godfrey K., Kettner H., Sharif F., Espasiano L., Gazzaley A., Wall M. B., Erritzoe D., Nutt D. J., Carhart-Harris R. L.","journal":"Nature Communications","publication_date":"2026-05-05","publication_year":2026,"doi":"10.1038/s41467-026-71962-3","pubmed_id":"42086570","openalex_id":"https://openalex.org/W4403392138","source_url":"https://doi.org/10.1038/s41467-026-71962-3","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Aging,Wellbeing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:47","bibtex":null,"source_record_id":"PMID:42086570","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1038/s41467-026-71962-3","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42086570","source_url":"https://doi.org/10.1038/s41467-026-71962-3","doi":"10.1038/s41467-026-71962-3","pmid":"42086570","publication_date":"2026-05-05","importer_version":"2.1.3","text_redistributed":false}},{"id":150,"title":"The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.","authors":"Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S","journal":"The British journal of psychiatry: the journal of mental science","publication_date":"2026-05-01","publication_year":2026,"doi":"10.1192/bjp.2025.102","pubmed_id":"40528492","openalex_id":"https://openalex.org/W4411430663","source_url":"https://pubmed.ncbi.nlm.nih.gov/40528492/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:50","bibtex":null,"source_record_id":"PMID:40528492","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40528492/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40528492","source_url":"https://pubmed.ncbi.nlm.nih.gov/40528492/","doi":"10.1192/bjp.2025.102","pmid":"40528492","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":436,"title":"Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.","authors":"Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ","journal":"Translational psychiatry","publication_date":"2025-11-13","publication_year":2025,"doi":"10.1038/s41398-025-03693-w","pubmed_id":"41257994","openalex_id":"https://openalex.org/W4416593366","source_url":"https://pubmed.ncbi.nlm.nih.gov/41257994/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Emotional Processing,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41257994","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41257994/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41257994","source_url":"https://pubmed.ncbi.nlm.nih.gov/41257994/","doi":"10.1038/s41398-025-03693-w","pmid":"41257994","publication_date":"2025-11-13","importer_version":"2.1.3","text_redistributed":false}},{"id":497,"title":"Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.","authors":"Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D","journal":"Comprehensive psychiatry","publication_date":"2025-10-01","publication_year":2025,"doi":"10.1016/j.comppsych.2025.152619","pubmed_id":"40618640","openalex_id":"https://openalex.org/W4411969620","source_url":"https://pubmed.ncbi.nlm.nih.gov/40618640/","substance_tags":"psilocybin","topic_tags":"Depression,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40618640","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40618640/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40618640","source_url":"https://pubmed.ncbi.nlm.nih.gov/40618640/","doi":"10.1016/j.comppsych.2025.152619","pmid":"40618640","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4303,"title":"A lexicon for psychedelic research and treatment","authors":"David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill","journal":"Drug Science Policy and Law","publication_date":"2025-08-31","publication_year":2025,"doi":"10.1177/20503245251380511","pubmed_id":null,"openalex_id":"https://openalex.org/W4414407628","source_url":"https://doi.org/10.1177/20503245251380511","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"DOI:10.1177/20503245251380511","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20503245251380511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245251380511","source_url":"https://doi.org/10.1177/20503245251380511","doi":"10.1177/20503245251380511","pmid":"","publication_date":"2025-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":631,"title":"Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.","authors":"Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L","journal":"Molecular psychiatry","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1038/s41380-025-03035-8","pubmed_id":"40281226","openalex_id":"https://openalex.org/W4409788022","source_url":"https://pubmed.ncbi.nlm.nih.gov/40281226/","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40281226","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40281226/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40281226","source_url":"https://pubmed.ncbi.nlm.nih.gov/40281226/","doi":"10.1038/s41380-025-03035-8","pmid":"40281226","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":710,"title":"Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.","authors":"Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D","journal":"Neuroscience and biobehavioral reviews","publication_date":"2025-05-01","publication_year":2025,"doi":"10.1016/j.neubiorev.2025.106132","pubmed_id":"40185376","openalex_id":"https://openalex.org/W4409174511","source_url":"https://pubmed.ncbi.nlm.nih.gov/40185376/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Longevity,Review Article,Animal Study","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40185376","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40185376/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40185376","source_url":"https://pubmed.ncbi.nlm.nih.gov/40185376/","doi":"10.1016/j.neubiorev.2025.106132","pmid":"40185376","publication_date":"2025-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":850,"title":"From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).","authors":"Zeifman RJ, Spriggs MJ, Kettner H, Lyons T, Rosas FE, Mediano PAM, Erritzoe D, Carhart-Harris RL","journal":"Scientific reports","publication_date":"2025-01-29","publication_year":2025,"doi":"10.1038/s41598-023-28111-3","pubmed_id":"39881126","openalex_id":"https://openalex.org/W4406959828","source_url":"https://pubmed.ncbi.nlm.nih.gov/39881126/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Wellbeing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39881126","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39881126/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39881126","source_url":"https://pubmed.ncbi.nlm.nih.gov/39881126/","doi":"10.1038/s41598-023-28111-3","pmid":"39881126","publication_date":"2025-01-29","importer_version":"2.1.3","text_redistributed":false}},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"openalex_id":"https://openalex.org/W4408526135","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:24","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105421","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105421","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","doi":"10.1016/j.nsa.2025.105421","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":878,"title":"An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.","authors":"Godfrey K, Weiss B, Zhang X, Spriggs M, Peill J, Lyons T, Carhart-Harris R, Erritzoe D","journal":"Neuroscience applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2024.104092","pubmed_id":"40654586","openalex_id":"https://openalex.org/W4404933083","source_url":"https://pubmed.ncbi.nlm.nih.gov/40654586/","substance_tags":"psilocybin","topic_tags":"Consciousness,Personality Change,Healthy Volunteers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40654586","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40654586/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40654586","source_url":"https://pubmed.ncbi.nlm.nih.gov/40654586/","doi":"10.1016/j.nsa.2024.104092","pmid":"40654586","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":848,"title":"Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.","authors":"O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D","journal":"Cureus","publication_date":"2025-01-01","publication_year":2025,"doi":"10.7759/cureus.78171","pubmed_id":"39882198","openalex_id":"https://openalex.org/W4406932478","source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","substance_tags":"psilocybin","topic_tags":"OCD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Randomized Controlled Trial","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39882198","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39882198","source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","doi":"10.7759/cureus.78171","pmid":"39882198","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":845,"title":"Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.","authors":"O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D","journal":"Cureus","publication_date":"2025-01-01","publication_year":2025,"doi":"10.7759/cureus.c209","pubmed_id":"39897296","openalex_id":"https://openalex.org/W4407008238","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","substance_tags":"psilocybin","topic_tags":"OCD,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39897296","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39897296","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","doi":"10.7759/cureus.c209","pmid":"39897296","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":664,"title":"Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.","authors":"Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL","journal":"Frontiers in psychology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.3389/fpsyg.2025.1580663","pubmed_id":"40547590","openalex_id":"https://openalex.org/W4411107182","source_url":"https://pubmed.ncbi.nlm.nih.gov/40547590/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40547590","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40547590/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40547590","source_url":"https://pubmed.ncbi.nlm.nih.gov/40547590/","doi":"10.3389/fpsyg.2025.1580663","pmid":"40547590","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":571,"title":"Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.","authors":"Blest-Hopley G, Pasculli G, Ruffell SGD, Tsang W, Emmanuel O, Pate KM, Kettner H, Roseman L, Erritzoe D, Carhart-Harris R","journal":"Frontiers in psychiatry","publication_date":"2025-01-01","publication_year":2025,"doi":"10.3389/fpsyt.2025.1594307","pubmed_id":"40842948","openalex_id":"https://openalex.org/W4413002573","source_url":"https://pubmed.ncbi.nlm.nih.gov/40842948/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Veterans","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40842948","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40842948/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40842948","source_url":"https://pubmed.ncbi.nlm.nih.gov/40842948/","doi":"10.3389/fpsyt.2025.1594307","pmid":"40842948","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":997,"title":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.","authors":"Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R","journal":"EClinicalMedicine","publication_date":"2024-10-01","publication_year":2024,"doi":"10.1016/j.eclinm.2024.102799","pubmed_id":"39764567","openalex_id":"https://openalex.org/W4402747955","source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Contraindications","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39764567","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39764567","source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","doi":"10.1016/j.eclinm.2024.102799","pmid":"39764567","publication_date":"2024-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1074,"title":"Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.","authors":"de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT","journal":"Scientific reports","publication_date":"2024-07-17","publication_year":2024,"doi":"10.1038/s41598-024-66817-0","pubmed_id":"39019922","openalex_id":"https://openalex.org/W4400737202","source_url":"https://pubmed.ncbi.nlm.nih.gov/39019922/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Spirituality,Clinical Trial,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:39019922","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39019922/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39019922","source_url":"https://pubmed.ncbi.nlm.nih.gov/39019922/","doi":"10.1038/s41598-024-66817-0","pmid":"39019922","publication_date":"2024-07-17","importer_version":"2.1.3","text_redistributed":false}},{"id":1122,"title":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.","authors":"Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R","journal":"Psychological medicine","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1017/s0033291723003653","pubmed_id":"38247730","openalex_id":"https://openalex.org/W4391109410","source_url":"https://pubmed.ncbi.nlm.nih.gov/38247730/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38247730","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38247730/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38247730","source_url":"https://pubmed.ncbi.nlm.nih.gov/38247730/","doi":"10.1017/s0033291723003653","pmid":"38247730","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1135,"title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.","authors":"Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E","journal":"Journal of affective disorders","publication_date":"2024-05-15","publication_year":2024,"doi":"10.1016/j.jad.2024.02.089","pubmed_id":"38423367","openalex_id":"https://openalex.org/W4392203910","source_url":"https://pubmed.ncbi.nlm.nih.gov/38423367/","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Aging,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:09","bibtex":null,"source_record_id":"PMID:38423367","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38423367/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38423367","source_url":"https://pubmed.ncbi.nlm.nih.gov/38423367/","doi":"10.1016/j.jad.2024.02.089","pmid":"38423367","publication_date":"2024-05-15","importer_version":"2.1.3","text_redistributed":false}},{"id":1148,"title":"Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.","authors":"Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2024-05-01","publication_year":2024,"doi":"10.1177/02698811241237870","pubmed_id":"38520045","openalex_id":"https://openalex.org/W4393118291","source_url":"https://pubmed.ncbi.nlm.nih.gov/38520045/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:09","bibtex":null,"source_record_id":"PMID:38520045","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38520045/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38520045","source_url":"https://pubmed.ncbi.nlm.nih.gov/38520045/","doi":"10.1177/02698811241237870","pmid":"38520045","publication_date":"2024-05-01","importer_version":"2.1.3","text_redistributed":false}}],"total":57,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":"David Erritzøe","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}